Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis.

Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators.

Neuroepidemiology. 2003 Mar-Apr;22(2):106-17. No abstract available.

PMID:
12656117
2.

The role of warfarin and aspirin in secondary prevention of stroke.

Elkind MS.

Curr Cardiol Rep. 2004 Mar;6(2):135-42. Review.

PMID:
14759359
3.

Current management of symptomatic intracranial stenosis: medical versus endovascular therapy.

Weigele JB, Taylor RA, Kasner SE.

Curr Atheroscler Rep. 2007 Oct;9(4):296-304. Review.

PMID:
18173957
5.

Warfarin versus aspirin in the secondary prevention of stroke: the WARSS study.

Redman AR, Allen LC.

Curr Atheroscler Rep. 2002 Jul;4(4):319-25. Review.

PMID:
12052284
6.

Warfarin versus aspirin for prevention of stroke in heart failure: a meta-analysis of randomized controlled clinical trials.

Kumar G, Goyal MK.

J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1279-87. doi: 10.1016/j.jstrokecerebrovasdis.2012.09.015. Epub 2012 Nov 20. Review.

PMID:
23182364
8.

The challenge of stroke prevention with intracranial arterial stenosis.

Turan TN, Smock A, Chimowitz MI.

Curr Cardiol Rep. 2013 Dec;15(12):422. doi: 10.1007/s11886-013-0422-y. Review.

9.

Clinical implication of antiembolic trials in atrial fibrillation and role of transesophageal echocardiography in atrial fibrillation.

Jagasia DH, Williams B, Ezekowitz MD.

Curr Opin Cardiol. 2000 Jan;15(1):58-63. Review.

PMID:
10666662
10.

Anticoagulants for prevention of ischemic stroke: current concepts.

Mohr JP.

Adv Neurol. 2003;92:263-70. Review. No abstract available.

PMID:
12760192
11.

Current management of symptomatic intracranial stenosis.

Taylor RA, Weigele JB, Kasner SE.

Curr Atheroscler Rep. 2011 Aug;13(4):321-9. doi: 10.1007/s11883-011-0183-2. Review.

PMID:
21597931
12.

Transient ischemic attack: risk stratification and treatment.

Cucchiara B, Ross M.

Ann Emerg Med. 2008 Aug;52(2):S27-39. doi: 10.1016/j.annemergmed.2008.05.019. Review.

PMID:
18655916
13.

Management of patients with symptomatic intracranial atherosclerosis.

Leung TW, Kwon SU, Wong KS.

Int J Stroke. 2006 Feb;1(1):20-5. doi: 10.1111/j.1747-4949.2005.00014.x. Review.

PMID:
18706064
14.

Transient ischemic attacks: Part II. Treatment.

Solenski NJ.

Am Fam Physician. 2004 Apr 1;69(7):1681-8. Review.

15.

MATCH results: implications for the internist.

Lutsep HL.

Am J Med. 2006 Jun;119(6):526.e1-7. Review.

PMID:
16750967
16.

Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials.

Pickett CA, Villines TC, Ferguson MA, Hulten EA.

Tex Heart Inst J. 2014 Aug 1;41(4):357-67. doi: 10.14503/THIJ-13-3879. eCollection 2014 Aug. Review.

Supplemental Content

Support Center